Login
Toggle navigation
Videos
Categories
Trending
Andrew Wilkinson, co-founder of Tiny Capital and WeCommerce, discussed WeCommerce's recent trading debut on CNBC with Scott Wapner.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Jordan Taub is the CEO of WeCommerce Holdings.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
John Howard on Australia's Role in the Iraq War and U.S. Alliance|John Howard
00:10:00
Record-Breaking Resilience in European Real Estate Investment Amid Global Uncertainty in 2016
00:10:00
Early stage companies with capital and expertise from active founders and operators|Ashley Mayer,Co-Founder and GP,Coalition Operators
00:10:00
Crescita is a growthoriented innovationdriven Canadian commercial dermatology company with inhouse R&D|Daniel N Chicoine,Chairman,Crescita Therapeutics Inc
00:10:00
"From Tax Law to Real Estate: A Decade of Opportunity with Bridge Investment Group"|CFO,Bridge Investment Group Holdings Inc
00:10:00
Arteris CEO sees big future in small FPGAs | K. Charles Janac, CEO, Arteris IncAIP:NMQ
00:10:00
Chris O'Shea, CEO of Centrica, sees his pay double to £8.2 million, as reported on BBC Breakfast.
00:10:00
Rockmaster Resources Advances Revel Ridge Drilling, Updates Resource
00:10:00
Riaan and Rudolph - Expert Investment Advisors at Everest Wealth
00:10:00
Lucara Diamond Corporation: Innovation, Sustainability, and Exceptional Diamond Recovery
00:10:00
Darren Koningen Unveils Company Story at Red Cloud Gold Conference |Darren Koningen, CEO & Director of Minera Alamos Inc.
00:10:00
Stavely Minerals' Chris Cairns on Copper-Gold-Silver Projects in Western Victoria | Chris Cairns , Managing Director, Stavely Minerals Ltd.